Long-Term Follow-Up of Patient with Diabetic Macular Edema Receiving Fluocinolone Acetonide Intravitreal Implant

INTRODUCTION: This case study aims to evaluate outcomes following fluocinolone acetonide [FAc 0.2 μg/day; ILUVIEN(®) (Alimera Sciences Limited, Aldershot, UK)] implant in a patient with diabetic macular edema (DME) not responding to laser photocoagulation or anti-vascular endothelial growth factor (...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertelmann, Thomas, Schulze, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470980/
https://www.ncbi.nlm.nih.gov/pubmed/25672501
http://dx.doi.org/10.1007/s40123-015-0028-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470980/
https://www.ncbi.nlm.nih.gov/pubmed/25672501
http://dx.doi.org/10.1007/s40123-015-0028-0

Ejemplares similares